Showing 81 - 90 of 14,967
This paper studies the impact of the first joint licensing platform for patented drugs, the Medicines Patent Pool, on global drug diffusion and innovation. The pool allows generic firms worldwide to license drug bundles cheaply and conveniently for sales in a set of developing countries. I...
Persistent link: https://www.econbiz.de/10013231463
The COVID pandemic underscores the need for fair access to health. In this paper, we propose a peer-to-peer business model for drug discovery, which democratizes the drug discovery process and reduce drug prices by cutting the intermediaries that stand between biomedical researchers and future...
Persistent link: https://www.econbiz.de/10013292211
Previous literature finds that larger downstream markets fuel the innovation of new technologies by incentivizing firms to spend more on R&D. Our evidence shows that larger markets also increase the extent of licensing-based cooperation between upstream innovators and downstream commercializers....
Persistent link: https://www.econbiz.de/10012927055
This paper contributes to the policy discussion on COVID-19 by presenting real-time evidence on the magnitude of the shock for Italian firms. We take advantage of unique panel data on 7,800 companies between January 2020 – right before the pandemic – and March of the same year – in the...
Persistent link: https://www.econbiz.de/10012834497
Maternal and newborn health in rural America suffers from a lack of obstetrical care, which is currently at crisis levels. Many state-level public policies have exacerbated or even initiated barriers to quality and access in rural healthcare. Such policies include certificate-of-need (CON) laws,...
Persistent link: https://www.econbiz.de/10012838566
The Healthcare Openness and Access Project (HOAP) is a collection of state-by-state comparative data on the flexibility and discretion that US patients and providers have in seeking and delivering healthcare. HOAP combines these data to produce 41 indicators of openness and accessibility. In...
Persistent link: https://www.econbiz.de/10012838644
Using panel data on immigrant populations from European, Asian and African countries the study estimates positive associations between the number of mobile applications in use aiming to facilitate immigrants' societal integration (m-Integration) and increased level of integration (Ethnosizer),...
Persistent link: https://www.econbiz.de/10012372890
Using panel data on immigrant populations from European, Asian and African countries the study estimates positive associations between the number of mobile applications in use aiming to facilitate immigrants’ societal integration (m-Integration) and increased level of integration (Ethnosizer),...
Persistent link: https://www.econbiz.de/10012389524
The nation's spending for prescription drugs has grown dramatically in recent years. Previous studies have shown that the replacement of older drugs by newer, more expensive, drugs is the single most important reason for this increase, but they did not measure how much of the difference between...
Persistent link: https://www.econbiz.de/10012786243
This paper explores how the regulatory approval process affects innovation incentives in medical technologies. Prior studies have found early mover regulatory advantages for drugs. I find the opposite for medical devices, where pioneer entrants spend 34 percent (7.2 months) longer than follow-on...
Persistent link: https://www.econbiz.de/10012935389